🇺🇸 FDA
Patent

US 8222225

Method of treating pneumoconiosis with oligodeoxynucleotides

granted A61KA61K31/7088A61P

Quick answer

US patent 8222225 (Method of treating pneumoconiosis with oligodeoxynucleotides) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/7088, A61P, A61P11/00, A61P11/08